Cargando…

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

INTRODUCTION: The clinical and economic consequences of the emergence of multidrug-resistant Gram-negative bacteria in the intensive care unit (ICU) setting, combined with the high mortality rate among patients with nosocomial pneumonia, have stimulated a search for alternative therapeutic options t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalopoulos, Argyris, Kasiakou, Sofia K, Mastora, Zefi, Rellos, Kostas, Kapaskelis, Anastasios M, Falagas, Matthew E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1065114/ https://www.ncbi.nlm.nih.gov/pubmed/15693967 http://dx.doi.org/10.1186/cc3020

Ejemplares similares

The significance of different formulations of aerosolized colistin
por: Michalopoulos, Argyris, et al.
Publicado: (2005)

Toxicity after prolonged (more than four weeks) administration of intravenous colistin
por: Falagas, Matthew E, et al.
Publicado: (2005)

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
por: Falagas, Matthew E, et al.
Publicado: (2005)

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Mubareka, Samira, et al.
Publicado: (2005)

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
por: Michalopoulos, Argyris S, et al.
Publicado: (2011)

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)

Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia
por: Almangour, Thamer A., et al.
Publicado: (2020)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
por: Falagas, Matthew E, et al.
Publicado: (2006)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
por: Feng, Xiaoxuan, et al.
Publicado: (2021)

The Antibacterial Activity of Kaempferol Combined with Colistin against Colistin-Resistant Gram-Negative Bacteria
por: Zhou, Huijing, et al.
Publicado: (2022)

Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
por: Tsimogianni, A, et al.
Publicado: (2006)

Impact of Vacuum-Assisted Closure (VAC) Therapy on Clinical Outcomes of Patients with Sternal Wound Infections: A Meta-Analysis of Non-Randomized Studies
por: Falagas, Matthew E., et al.
Publicado: (2013)

Naringenin restores colistin activation against colistin-resistant gram-negative bacteria in vitro and in vivo
por: Xu, Mengxin, et al.
Publicado: (2022)

Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin
por: Zhang, Yi, et al.
Publicado: (2023)

Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
por: Wainwright, C E, et al.
Publicado: (2009)

Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria in Vitro and in Vivo
por: Zhang, Ying, et al.
Publicado: (2021)

Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins
por: Hashemi, Marjan M., et al.
Publicado: (2017)

Pharmacokinetics of colistin in patients with multidrug-resistant Gram-negative infections: A pilot study
por: Gautam, Vikas, et al.
Publicado: (2018)

Colistin Treatment for Multidrug-Resistant Gram-Negative Infections in Children: Caution Required for Nephrotoxicity
por: Ustundag, Gulnihan, et al.
Publicado: (2022)

Disrupting iron homeostasis can potentiate colistin activity and overcome colistin resistance mechanisms in Gram-Negative Bacteria
por: Gadar, Kavita, et al.
Publicado: (2023)

Age Distribution of Cases of 2009 (H1N1) Pandemic Influenza in Comparison with Seasonal Influenza
por: Karageorgopoulos, Drosos E., et al.
Publicado: (2011)

Trends of Mortality due to Septicemia in Greece: An 8-Year Analysis
por: Falagas, Matthew E., et al.
Publicado: (2013)

Using Colistin as a Trojan Horse: Inactivation of Gram-Negative Bacteria with Chlorophyllin
por: Richter, Peter, et al.
Publicado: (2019)

Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin
por: Yao, Zhuocheng, et al.
Publicado: (2022)

Synergistic Activity and Biofilm Formation Effect of Colistin Combined with PFK-158 Against Colistin-Resistant Gram-Negative Bacteria
por: Chen, Liqiong, et al.
Publicado: (2021)

Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
por: Zhang, Qi, et al.
Publicado: (2022)

Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
por: Pavleas, J, et al.
Publicado: (2006)

Intravenous colistin in the treatment of multidrug-resistant gram-negative organism in tertiary hospital, Jazan, KSA
por: Ali, Eman M., et al.
Publicado: (2021)

Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015)

Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Vietnam: Antibiotic Resistance, Treatment Outcomes, and Colistin-Associated Adverse Effects
por: Vo, Thu Pham Minh, et al.
Publicado: (2022)

Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study
por: Doshi, Neha M, et al.
Publicado: (2013)

Synthetic Teichoic Acid Conjugate Vaccine against Nosocomial Gram-Positive Bacteria
por: Laverde, Diana, et al.
Publicado: (2014)

Comparative Evaluation of CHROMagar COL-APSE, MicroScan Walkaway, ComASP Colistin, and Colistin MAC Test in Detecting Colistin-resistant Gram-Negative Bacteria
por: Osei Sekyere, John, et al.
Publicado: (2020)

New Multidrug Efflux Inhibitors for Gram-Negative Bacteria
por: Marshall, Robert L., et al.
Publicado: (2020)

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

SuperPolymyxin™ Medium for the Screening of Colistin-Resistant Gram-Negative Bacteria in Stool Samples
por: Przybysz, Sara M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p410acfetc42j4v6fl9q4m4pqu